Tue, March 5, 2024

Francois Brisebois Maintained (AVDL) at Buy with Increased Target to $29 on, Mar 5th, 2024

Francois Brisebois of Oppenheimer, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Buy with Increased Target from $27 to $29 on, Mar 5th, 2024.

Francois has made no other calls on AVDL in the last 4 months.



There is 1 other peer that has a rating on AVDL. Out of the 1 peers that are also analyzing AVDL, 0 agree with Francois's Rating of Hold.



This is the rating of the analyst that currently disagrees with Francois


  • Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $21 on, Tuesday, February 6th, 2024